Lumify Maximum Dose
For adults and children 5 years and older, Lumify (brimonidine tartrate 0.025%) should not be used more than 4 times daily, with 1 drop instilled in the affected eye(s) per application 1.
Dosing Specifications
Adults and Children ≥5 Years
- Frequency: Maximum 4 times daily
- Dose per application: 1 drop in affected eye(s)
- Formulation: Single-use vials (0.4 mL each) or multi-dose bottles
- Administration: Discard single-use vials immediately after use; do not re-use 1
Children <5 Years
- Not recommended: Consult a doctor before use 1
- The FDA labeling does not provide dosing for this age group, indicating insufficient safety and efficacy data
Important Administration Guidelines
Contact lens wearers must remove lenses before instillation and wait at least 10 minutes before reinserting 1.
When using multiple ophthalmic products, wait at least 5 minutes between each product to prevent dilution and ensure proper absorption 1.
Clinical Context
The 4-times-daily maximum is based on clinical trials demonstrating:
- Efficacy maintained for up to 8 hours per dose 2, 3
- No tachyphylaxis (tolerance) with regular use over 4 weeks 2, 3
- Minimal rebound redness upon discontinuation 2, 3
- Excellent safety profile with infrequent adverse events 2
Exceeding the maximum dose of 4 times daily is not recommended as it has not been studied and may increase the risk of adverse effects without additional therapeutic benefit. The 8-hour duration of action supports the 4-times-daily dosing schedule as adequate for continuous redness relief throughout waking hours.
Critical Safety Note
This low-dose formulation (0.025%) is specifically for ocular redness relief and differs significantly from higher-concentration brimonidine formulations (0.15%, 0.2%) used for glaucoma treatment, which have different dosing schedules and indications.